Several studies have demonstrated that CDK5 and its specific activator protein p35 were important for spontaneous metastasis and CDK5/p35 may represent a biomarker for prognosis in patients with prostate and lung cancer [6, 8, 12]. This evidence concerns the gene CDK5 and lung cancer.